XML 32 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Note 8 - Accrued Expenses
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]

Note 8.  Accrued Expenses

 

Accrued expenses consist of the following as of March 31, 2024 and  December 31, 2023 (in thousands):

 

  

March 31,

  

December 31,

 
  

2024

  

2023

 

Accrued payroll and bonus

 $2,786  $2,255 

Property and franchise taxes accrual

  331   251 

Severance and other termination benefits

  170   436 

Accrued other miscellaneous liabilities

  527   760 

Total accrued expenses

 $3,814  $3,702 

 

As previously disclosed in our Annual Report, we implemented certain restructuring efforts during 2023 to streamline our tracer diagnostics operations, consolidate facilities in the United States and Mexico, for Repeat Precision, and to eliminate redundancies in the structure of certain U.S. and international operations management and support functions. In addition, in July 2023, an executive officer and NCS agreed that he would leave his position. In connection with these restructuring efforts, we incurred severance and other charges of $1.9 million in 2023. Of this amount, we paid $1.1 million in 2023 and $0.2 million for the three months ended  March 31, 2024, with a remaining severance and other termination benefits accrual of $0.2 million as of March 31, 2024. We expect this severance and other termination benefits liability to be fully paid by July 2024.